These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9540136)

  • 1. Carvedilol in the treatment of hypertension--a review of the clinical data base.
    Hansson L; Himmelmann A
    Scand Cardiovasc J Suppl; 1998; 47():67-80. PubMed ID: 9540136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical and clinical pharmacology of carvedilol.
    Ruffolo RR; Boyle DA; Venuti RP; Lukas MA
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S2-15. PubMed ID: 8487245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    McTavish D; Campoli-Richards D; Sorkin EM
    Drugs; 1993 Feb; 45(2):232-58. PubMed ID: 7681374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new molecule with vasodilating and beta-adrenoceptor blocking properties.
    Abshagen U
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S23-32. PubMed ID: 2454364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiency.
    Gehr TW; Tenero DM; Boyle DA; Qian Y; Sica DA; Shusterman NH
    Eur J Clin Pharmacol; 1999 Jun; 55(4):269-77. PubMed ID: 10424319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
    Ruffolo RR; Feuerstein GZ
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the antihypertensive drugs carvedilol, doxazosin and moxonidine].
    Dominiak P
    Wien Med Wochenschr; 1995; 145(15-16):373-82. PubMed ID: 7502518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection.
    Feuerstein GZ; Ruffolo RR
    Eur Heart J; 1995 Jul; 16 Suppl F():38-42. PubMed ID: 8521883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A; Heidland A; Pangerl A; Meyer-Sabellek W; Schaefer RM
    Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of therapy with carvedilol, a beta-blocker vasodilator with antioxidant properties, in hypertensive patients.
    Moser M; Frishman W
    Am J Hypertens; 1998 Jan; 11(1 Pt 2):15S-22S. PubMed ID: 9503102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and efficacy of carvedilol in chronic hemodialysis patients with hypertension.
    Miki S; Masumura H; Kaifu Y; Yuasa S
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S62-8. PubMed ID: 1721982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilatory action of carvedilol.
    Sponer G; Strein K; Bartsch W; Müller-Beckmann B
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S5-11. PubMed ID: 1378150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
    Bril A; Slivjak M; DiMartino MJ; Feuerstein GZ; Linee P; Poyser RH; Ruffolo RR; Smith EF
    Cardiovasc Res; 1992 May; 26(5):518-25. PubMed ID: 1359930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics and pharmacodynamics of carvedilol.
    Morgan T
    Clin Pharmacokinet; 1994 May; 26(5):335-46. PubMed ID: 7914479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carvedilol: molecular and cellular basis for its multifaceted therapeutic potential.
    Cheng J; Kamiya K; Kodama I
    Cardiovasc Drug Rev; 2001; 19(2):152-71. PubMed ID: 11484068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection.
    Feuerstein GZ; Ruffolo RR
    Eur Heart J; 1996 Apr; 17 Suppl B():24-9. PubMed ID: 8733068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.
    Dunn CJ; Lea AP; Wagstaff AJ
    Drugs; 1997 Jul; 54(1):161-85. PubMed ID: 9211087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with dual-acting drugs in hypertension.
    Rahn KH
    Clin Investig; 1992; 70 Suppl 1():S39-42. PubMed ID: 1350483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carvedilol--clinical experience in arrhythmias.
    Storstein L
    Cardiology; 1993; 82 Suppl 3():29-33. PubMed ID: 8106161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Carvedilol].
    Antepohl W; Herzig S; Böhm M
    Dtsch Med Wochenschr; 1997 Jun; 122(25-26):833-4. PubMed ID: 9244672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.